1. Nuhu F, Bhandari S. Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia. Pharmaceuticals (Basel). 2018;11(4):103. [
View at Publisher] [
DOI] [
PMID] [
]
2. Zordoky BNM, El-Kadi AOS. Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure. Curr Drug Metab. 2008;9(2):122-8. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
3. Ghroubi S, Elleuch W, Abid L, Abdenadher M, Kammoun S, Elleuch MH. Effects of a low-intensity dynamic-resistance training protocol using an isokinetic dynamometer on muscular strength and aerobic capacity after coronary artery bypass grafting. Ann Phys Rehabil Med. 2013;56(2):85-101. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
4. Gao FJ, Yao KP, Tsai CS, Wang KY. Predictors of health care needs in discharged patients who have undergone coronary artery bypass graft surgery. Heart Lung. 2009;38(3):182-91. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
5. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009;119(12):1661-70. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
6. Withers SB, Agabiti-Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA, et al. Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol. 2011;31(4):908-13. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
7. Sorescu D, Weiss D, Lassègue B, Clempu RE, Szöcs K, Sorescu GP, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105(12):1429-35. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
8. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-208. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
9. Lazzarino G, Raatikainen P, Nuutinen M, Nissinen J, Tavazzi B, Di Pierro D, et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation. 1994;90(1):291-7. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
10. Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, et al. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. J Nutr Biochem. 2010;21(12):1238-50. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
11. Sim SC, Ingelman-Sundberg M. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database. Methods Mol Biol. 2013;987:251-9. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
12. Nelson DR, Zeldin DC, Hoffman SMG, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 2004;14(1):1-18. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
13. Zhang K, Wang J, Zhang H, Chen J, Zuo Z, Wang J, et al. Mechanisms of epoxyeicosatrienoic acids to improve cardiac remodeling in chronic renal failure disease. Eur J Pharmacol. 2013;701(1-3):33-9. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
14. Michaud V, Frappier M, Dumas MC, Turgeon J. Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism. PloS One. 2010; 5(12): e15666. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
15. Sellke FW, Ruel M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg. 2003;75(2):S685-90. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
16. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA. 2013;310(19):2086-95. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
17. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342(7):454-60. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
18. Schumacher B, Peecher P, Von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation. 1998;97(7):645-50. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
19. Moholdt TT, Amundsen BH, Rustad LA, Wahba A, Løvø KT, Gullikstad LR, et al. Aerobic interval training versus continuous moderate exercise after coronary artery bypass surgery: a randomized study of cardiovascular effects and quality of life. Am Heart J. 2009;158(6):1031-7. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
20. Osailan A, Abdelbasset WK. Exercise-based cardiac rehabilitation for postcoronary artery bypass grafting and its effect on hemodynamic responses and functional capacity evaluated using the Incremental Shuttle Walking Test: A retrospective pilot analysis. J Saudi Heart Assoc. 2020;32(1):25-33. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
21. Mrakic-Sposta S, Gussoni M, Montorsi M, Porcelli S, Vezzoli A. A quantitative method to monitor reactive oxygen species production by electron paramagnetic resonance in physiological and pathological conditions. Oxid Med Cell Longev. 2014;2014:306179. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
22. Fukuda T, Kurano M, Fukumura K, Yasuda T, Iida H, Morita T, et al. Cardiac rehabilitation increases exercise capacity with a reduction of oxidative stress. Korean Circ J. 2013;43(7):481-7. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
23. Wan S, Leclerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest. 1997:112(3):676-92. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
24. Church TS, Lavie CJ, Milani RV, Kirby GS. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J 2002;143:349-55. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
25. Fukuda T, Kurano M, Fukumura K, Yasuda T, Iida H, Morita T, et al. Cardiac rehabilitation increases exercise capacity with a reduction of oxidative stress. Korean Circ J. 2013;43(7):481-7. [
View at Publisher] [
DOI] [
PMID] [
]
26. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, et al. Antioxidative effects of exercise training in patients with chronic heart failure: Increase in radical scavenger enzyme activity in skeletal muscle. Circulation. 2005;111(14):1763-70. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
27. Davies SW, Duffy JP, Wickens DG, Underwood SM, Hill A, Alladine MF, et al. Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;105(6): 979-87. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
28. Meirelles LR, Matsuura C, Resende ADC, Salgado ÂA, Pereira NR, Coscarelli PG, et al. Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients. Eur J Prev Cardiol. 2014;21(10):1225-32. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
29. Bleau AM, Levitchi MC, Maurice H, Du Souich P. Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: The role of cytokines. Br J Pharmacol. 2000;130(8):1777-84. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
30. Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics. 2007;17(9):731-42. [
DOI] [
PMID] [
Google Scholar]
31. Serruvs PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-72. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
32. Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009;8(10):794-805. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
33. Lavie CJ, Milani R V, Ventura HO, Messerli FH, Murgo JP. Cardiac rehabilitation, exercise training, and preventive cardiology research at Ochsner Heart and Vascular Institute. Tex Hear Inst J. 1995;22(1):44-52. [
View at Publisher] [
Google Scholar]
34. Church TS, Lavie CJ, Milani RV, Kirby GS. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J. 2002;143(2):349-55. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]